Paper40434646
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling.
Ota N and 24 others. Proc Natl Acad Sci U S A, 2025. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling. Papers, record 40434646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40434646
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin-23 | Major topic |
| Single-Domain Antibodies | Major topic |
| Signal Transduction | Major topic |
| Peptide Hydrolases | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Administration, Oral | |
| Protein Engineering | |
| Colitis | |
| Inflammatory Bowel Diseases |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 GM124165 | NIGMS NIH HHS | United States | P30GM124165 | PubMed and NIH | NIH RePORTER |
| P30 GM124169 | NIGMS NIH HHS | United States | P30GM124169 | PubMed and NIH | NIH RePORTER |
| S10 OD021832 | NIH HHS | United States | S10OD021832 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 40802696 | Correction for Ota et al., Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling. | https://conductscience.org/library/papers/40802696 |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34460338 | A non-clinical comparative study of IL-23 antibodies in psoriasis. | MAbs | 2021 | https://conductscience.org/library/papers/34460338 | PubMed |
| 2 | 21460454 | REFMAC5 for the refinement of macromolecular crystal structures. | Acta Crystallogr D Biol Crystallogr | 2011 | https://conductscience.org/library/papers/21460454 | PubMed |
| 3 | 23915679 | Gastrointestinal transit measurements in mice with 99mTc-DTPA-labeled activated charcoal using NanoSPECT-CT. | EJNMMI Res | 2013 | https://conductscience.org/library/papers/23915679 | PubMed |
| 4 | 27754618 | Processing of X-ray diffraction data collected in oscillation mode. | Methods Enzymol | 1997 | https://conductscience.org/library/papers/27754618 | PubMed |
| 5 | 29569425 | Comparative analysis of nanobody sequence and structure data. | Proteins | 2018 | https://conductscience.org/library/papers/29569425 | PubMed |
| 6 | 29287995 | Structural Activation of Pro-inflammatory Human Cytokine IL-23 by Cognate IL-23 Receptor Enables Recruitment of the Shared Receptor IL-12Rβ1. | Immunity | 2018 | https://conductscience.org/library/papers/29287995 | PubMed |
| 7 | 38438014 | Colitis-Induced Small Intestinal Hypomotility Is Dependent on Enteroendocrine Cell Loss in Mice. | Cell Mol Gastroenterol Hepatol | 2024 | https://conductscience.org/library/papers/38438014 | PubMed |
| 8 | 20124692 | XDS. | Acta Crystallogr D Biol Crystallogr | 2010 | https://conductscience.org/library/papers/20124692 | PubMed |
| 9 | 28057863 | Mutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational dynamics and antigen binding. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28057863 | PubMed |
| 10 | 38936360 | Preclinical proof of principle for orally delivered Th17 antagonist miniproteins. | Cell | 2024 | https://conductscience.org/library/papers/38936360 | PubMed |
| 11 | 17068223 | A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. | Science | 2006 | https://conductscience.org/library/papers/17068223 | PubMed |
| 12 | 23406896 | Antibody biodistribution coefficients: inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human. | MAbs | 2013 | https://conductscience.org/library/papers/23406896 | PubMed |
| 13 | 37468638 | Mega-scale experimental analysis of protein folding stability in biology and design. | Nature | 2023 | https://conductscience.org/library/papers/37468638 | PubMed |
| 14 | 28325875 | Ab initio solution of macromolecular crystal structures without direct methods. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28325875 | PubMed |
| 15 | 31575982 | Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis Patients. | Sci Rep | 2019 | https://conductscience.org/library/papers/31575982 | PubMed |
| 16 | 16919486 | Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. | Immunity | 2006 | https://conductscience.org/library/papers/16919486 | PubMed |
| 17 | 1560463 | Antibody framework residues affecting the conformation of the hypervariable loops. | J Mol Biol | 1992 | https://conductscience.org/library/papers/1560463 | PubMed |
| 18 | 37003258 | Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut. | Cell Host Microbe | 2023 | https://conductscience.org/library/papers/37003258 | PubMed |
| 19 | 26896086 | Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease. | J Crohns Colitis | 2016 | https://conductscience.org/library/papers/26896086 | PubMed |
| 20 | 2052525 | Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. | Pharm Res | 1991 | https://conductscience.org/library/papers/2052525 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42723759 | Narrative review of research progress and future development of bispecific antibodies in lung cancer: opportunities and challenges. | Transl Lung Cancer Res | 2026 | https://conductscience.org/library/papers/42723759 | PubMed |
| 41880566 | A modular platform for Sterically Masked Activated Cytokines (SMACks). | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41880566 | PubMed |
| 41745409 | Interleukin-23p19 Inhibitors in Inflammatory Bowel Disease: From Current Insights to Future Directions. | J Pers Med | 2026 | https://conductscience.org/library/papers/41745409 | PubMed |
| 41675494 | Deciphering the immunocellular regulatory network in inflammatory bowel disease: from susceptibility genes to cellular effectors and toward precision therapies. | Front Immunol | 2025 | https://conductscience.org/library/papers/41675494 | PubMed |
| 41524227 | Antibody-Empowered Nanomedicine for Precise Biomedical Applications. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41524227 | PubMed |
| 41421354 | Engineered probiotics platform for oral delivery of antibody as a high-compliance alternative for immune-mediated inflammatory diseases. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/41421354 | PubMed |
| 41193399 | From discovery to the clinic: structural insights, engineering options, clinical, and 'next wave' applications of camelid-derived single-domain antibodies. | MAbs | 2025 | https://conductscience.org/library/papers/41193399 | PubMed |
| 40775487 | Fifty years of monoclonals: the past, present and future of antibody therapeutics. | Nat Rev Immunol | 2025 | https://conductscience.org/library/papers/40775487 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40434646
GET https://conductscience.org/api/papers/v1/40434646/authors?page=2